News | April 21, 2023
SÜDPACK’s PharmaGuard blister concept to add to sustainability
SÜDPACK is setting standards in terms of both performance and sustainability
SÜDPACK is setting standards in terms of both performance and sustainability
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Acquisition positions Chiesi to expand patient access to approved treatments and advance efforts to develop new treatments for people living with rare diseases.
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
Science communication brings behavioural changes
Urges everyone to follow COVID Appropriate Behaviour and curb any misinformation
The Award acknowledges Emcure's contribution in the field of HIV/AIDS to improve the quality of life of people living with HIV/AIDS.
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Acetazolamide is used to treat glaucoma
Subscribe To Our Newsletter & Stay Updated
